Benzinga··Usa News GroupRegenerative Medicine's New Player: How Conexeu Sciences Is Redefining Tissue Engineering
Conexeu Sciences ($CNXU) debuts on Nasdaq, offering scalable regenerative tissue platform targeting wound care and reconstruction markets with 510(k) submission planned for early 2027.
MESOBVSIARTCNXUEOLSIPOregenerative medicine